Arcadia BiosciencesRKDA
13F holders, Q4 2024 (December 31)13holders
2new positions
3sold out
$5.92avg. 13F price*
At the end of Q4 2024, 13 institutions reported holding Arcadia Biosciences Inc. (RKDA) in their 13F filings, unchanged from Q3 2024. 2 opened new positions and 3 sold out. The largest holders were Mariner, LLC ($148K), Vanguard Group Inc. ($83K) and UBS Group AG ($83K).
- Company
- Arcadia Biosciences Inc.
- CUSIP
- 039014303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $74K |
| Exits | 3 | $5K |
All 13F filers, Q3 2024 → Q4 2024: 26,275 shares bought and 1,773 shares sold, net +24,502 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Mariner, LLC | 0.00% | No change | 25,000 | $148K |
| Vanguard Group Inc. | 0.00% | No change | 14,038 | $83K |
| UBS Group AG | 0.00% | Add +5734.7% | 13,945 | $83K |
| Geode Capital Management, LLC | 0.00% | New | 12,297 | $73K |
| State Street Corp. | 0.00% | No change | 12,146 | $72K |
| Morgan Stanley | 0.00% | No change | 607 | $4K |
| Atticus Wealth Management, LLC | 0.00% | New | 272 | $2K |
| SBI Securities Co., Ltd. | 0.00% | — | 120 | $710 |
| Osaic Holdings, Inc. | 0.00% | No change | 75 | $444 |
| Group One Trading LLC | 0.00% | No change | 18 | $107 |
| Bank of America Corp. | 0.00% | No change | 11 | $65 |
| Assetmark, Inc. | 0.00% | No change | 5 | $30 |
| Harbour Investments, Inc. | 0.00% | No change | 1 | $6 |
"% of holder's portfolio" is RKDA's weight in each manager's 13F, not the share of Arcadia Biosciences Inc. the manager owns.